top of page

A clinical trial of transcranial magnetic stimulation (TMS) in autism spectrum disorder

TMS is a form of non-invasive brain stimulation. It is administered through a plastic-coated metallic coil that generates brief but powerful magnetic pulses. When these pulses are delivered to the scalp, they create a small amount of electricity in the brain that stimulates nerve cells.

Participants in this study will undergo 20 sessions of TMS. In this study, we apply TMS to a region of the brain called the right temporoparietal junction, or rTPJ. The rTPJ is a part of the brain that is involved in social understanding and social communication.

Some participants will receive the real form of TMS, while others will receive a sham or placebo form. The sham or placebo form mimics the feeling of TMS, but no brain stimulation is delivered.

Find out more on the study website.

Recruitment

To be eligible for this study, participants must be:

  • Aged 14 - 40 years old

  • Have a formal autism diagnosis

  • Be fluent/proficient in English

Not have any medical condition listed in the exclusion criteria

This study is currently OPEN. Register your interest below. 

Contact CAN Research

Brain and Mind Centre

University of Sydney

94 Mallet Street

Camperdown, NSW, 2050

Tel: 02 9114 4104

Final_CAN_logo_2022 (1).png

The Children’s Hospital at Westmead

Cnr Hawkesbury Road & Hainsworth Street

Westmead, NSW, 2145

We use identity-first language (autistic person)  rather than person-first language (person with autism) throughout the site.
Find out more about our decision to do so. 

 

Privacy Policy

bottom of page